These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20813094)

  • 21. Discovery of salermide-related sirtuin inhibitors: binding mode studies and antiproliferative effects in cancer cells including cancer stem cells.
    Rotili D; Tarantino D; Nebbioso A; Paolini C; Huidobro C; Lara E; Mellini P; Lenoci A; Pezzi R; Botta G; Lahtela-Kakkonen M; Poso A; Steinkühler C; Gallinari P; De Maria R; Fraga M; Esteller M; Altucci L; Mai A
    J Med Chem; 2012 Dec; 55(24):10937-47. PubMed ID: 23189967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of Ca2+ in baicalein-induced apoptosis in human breast MDA-MB-231 cancer cells through mitochondria- and caspase-3-dependent pathway.
    Lee JH; Li YC; Ip SW; Hsu SC; Chang NW; Tang NY; Yu CS; Chou ST; Lin SS; Lino CC; Yang JS; Chung JG
    Anticancer Res; 2008; 28(3A):1701-11. PubMed ID: 18630529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel triterpenoid 25-hydroxy-3-oxoolean-12-en-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
    Rabi T; Wang L; Banerjee S
    Breast Cancer Res Treat; 2007 Jan; 101(1):27-36. PubMed ID: 17028990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-kappaB signaling pathway.
    Kuo PL; Hsu YL; Lin TC; Tzeng WS; Chen YY; Lin CC
    Cancer Lett; 2007 Apr; 248(2):280-91. PubMed ID: 16963181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equol induces apoptosis through cytochrome c-mediated caspases cascade in human breast cancer MDA-MB-453 cells.
    Choi EJ; Ahn WS; Bae SM
    Chem Biol Interact; 2009 Jan; 177(1):7-11. PubMed ID: 18973749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Function of the SIRT1 protein deacetylase in cancer.
    Stünkel W; Peh BK; Tan YC; Nayagam VM; Wang X; Salto-Tellez M; Ni B; Entzeroth M; Wood J
    Biotechnol J; 2007 Nov; 2(11):1360-8. PubMed ID: 17806102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
    Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
    Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.
    Shi YK; Li ZH; Han XQ; Yi JH; Wang ZH; Hou JL; Feng CR; Fang QH; Wang HH; Zhang PF; Wang FS; Shen J; Wang P
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1131-40. PubMed ID: 20838997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis.
    Puca R; Nardinocchi L; Starace G; Rechavi G; Sacchi A; Givol D; D'Orazi G
    Free Radic Biol Med; 2010 May; 48(10):1338-46. PubMed ID: 20171273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of reactive oxygen species/c-Jun NH(2)-terminal kinase pathway in kotomolide A induces apoptosis in human breast cancer cells.
    Kuo PL; Chen CY; Tzeng TF; Lin CC; Hsu YL
    Toxicol Appl Pharmacol; 2008 Jun; 229(2):215-26. PubMed ID: 18374381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The critical role of the class III histone deacetylase SIRT1 in cancer.
    Liu T; Liu PY; Marshall GM
    Cancer Res; 2009 Mar; 69(5):1702-5. PubMed ID: 19244112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SIRT1 inhibition by melatonin exerts antitumor activity in human osteosarcoma cells.
    Cheng Y; Cai L; Jiang P; Wang J; Gao C; Feng H; Wang C; Pan H; Yang Y
    Eur J Pharmacol; 2013 Sep; 715(1-3):219-29. PubMed ID: 23726949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and primary activity assay of tripeptidomimetics as histone deacetylase inhibitors with linear linker and branched cap group.
    Zhang Y; Feng J; Jia Y; Xu Y; Liu C; Fang H; Xu W
    Eur J Med Chem; 2011 Nov; 46(11):5387-97. PubMed ID: 21924799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PA-MSHA inhibits proliferation and induces apoptosis through the up-regulation and activation of caspases in the human breast cancer cell lines.
    Liu ZB; Hou YF; ; Di GH; Wu J; Shen ZZ; Shao ZM
    J Cell Biochem; 2009 Sep; 108(1):195-206. PubMed ID: 19562667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells.
    Im JY; Park H; Kang KW; Choi WS; Kim HS
    Chem Biol Interact; 2008 Apr; 172(3):235-44. PubMed ID: 18313654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
    Rahim R; Strobl JS
    Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of novel indole based small molecules as anticancer agents through SIRT1 inhibition.
    Panathur N; Dalimba U; Koushik PV; Alvala M; Yogeeswari P; Sriram D; Kumar V
    Eur J Med Chem; 2013 Nov; 69():125-38. PubMed ID: 24013412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel, selective, and stable inhibitors of class II histone deacetylases. Validation studies of the inhibition of the enzymatic activity of HDAC4 by small molecules as a novel approach for cancer therapy.
    Ontoria JM; Altamura S; Di Marco A; Ferrigno F; Laufer R; Muraglia E; Palumbi MC; Rowley M; Scarpelli R; Schultz-Fademrecht C; Serafini S; Steinkühler C; Jones P
    J Med Chem; 2009 Nov; 52(21):6782-9. PubMed ID: 19888759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and preliminary biological evaluation of N-hydroxy-4-(3-phenylpropanamido)benzamide (HPPB) derivatives as novel histone deacetylase inhibitors.
    Jiao J; Fang H; Wang X; Guan P; Yuan Y; Xu W
    Eur J Med Chem; 2009 Nov; 44(11):4470-6. PubMed ID: 19608304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inhibitory and apoptosis regulating effects of adriamycin on different human breast cancer cell lines].
    Yu ZY; Zuo WS; Wei L; Shan PY; Song XR; Liu YT; Liu YS; Zhou ZB; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):19-22. PubMed ID: 15808069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.